BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
2.160
-0.030 (-1.37%)
At close: Aug 28, 2026, 4:00 PM EDT
2.189
+0.029 (1.33%)
After-hours: Aug 28, 2026, 7:59 PM EDT
BioVie Employees
BioVie had 13 employees as of June 30, 2026. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,701,262
Market Cap
16.29M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 13 | 0 | - | 13 | 0 |
| Jun 30, 2025 | 13 | -1 | -7.14% | 13 | 0 |
| Jun 30, 2024 | 14 | -4 | -22.22% | 14 | 0 |
| Jun 30, 2023 | 18 | 5 | 38.46% | 18 | 0 |
| Jun 30, 2022 | 13 | 7 | 116.67% | 13 | 0 |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Citius Pharmaceuticals | 23 |
| BioCardia | 21 |
| Lisata Therapeutics | 21 |
| NeuroSense Therapeutics | 17 |
| CalciMedica | 16 |
| Psyence Biomedical | 12 |
| AEON Biopharma | 8 |
BIVI News
- 16 days ago - BioVie Registration statement: Registration filing - Filings
- 17 days ago - BioVie Annual report: Q4 2026 - Filings
- 18 days ago - BioVie Transcript: Study result - Transcripts
- 18 days ago - BioVie Slides: Study result - Filings
- 18 days ago - BioVie Press release: Study result - Filings
- 24 days ago - BioVie says Phase 2 SUNRISE-PD trial of bezisterim met primary endpoint - TheFly
- 24 days ago - BioVie Registration statement: Registration filing - Filings
- 24 days ago - BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson's Disease - GlobeNewsWire